These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2285001)

  • 41. [Assessment by transcutaneous PO2 measurement of the treatment of venous ulcers with naftidrofuryl].
    Kalis B
    J Mal Vasc; 1984; 9(2):133-6. PubMed ID: 6747475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 43. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
    Grossmann WM; Standl A; May U; van Laak HH; Hirche H
    Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
    Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Trust Study Group.
    Lancet; 1990 Nov; 336(8725):1205-9. PubMed ID: 1978069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
    Barradell LB; Brogden RN
    Drugs Aging; 1996 Apr; 8(4):299-322. PubMed ID: 8920176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemorrheological, micro- and macrocirculatory effects of naftidrofuryl in an acute study: a randomized, placebo-controlled, double-blind individual comparison.
    Jung F; Kiesewetter H; Mrowietz C; Leipnitz G; Braun B; Wappler M; Scheffler P; Wenzel E
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):507-14. PubMed ID: 3679623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of naftidrofuryl on transcutaneous oxygen tension during a treadmill test in patients with peripheral arterial occlusive disease.
    Mouren X; Caillard P; Bensoussan JJ; Massonneau M; Gamand S; Stevens WH
    Vasc Med; 1998; 3(1):9-14. PubMed ID: 9666526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 50. A single blind study of naftidrofuryl in the treatment of peripheral vascular disorders in general practice.
    Clyne MB; Lask A
    Br J Clin Pract; 1978 Jun; 32(6):169-71. PubMed ID: 354670
    [No Abstract]   [Full Text] [Related]  

  • 51. Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program.
    Spengel F; Clément D; Boccalon H; Liard F; Brown T; Lehert P
    Int Angiol; 2002 Mar; 21(1):20-7. PubMed ID: 11941270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C; Kühn A; Strauss R; Hübsch-Müller C; Kübler W
    Vasa Suppl; 1989; 28():26-30. PubMed ID: 2609241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
    Jung F; Wolf S; Kiesewetter H
    Arzneimittelforschung; 1989 Oct; 39(10):1277-80. PubMed ID: 2610721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.
    Federico F; Lucivero V; Lamberti P; Fiore A; Conte C
    Ital J Neurol Sci; 1991 Dec; 12(6):557-63. PubMed ID: 1783533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous naftidrofuryl for critical limb ischaemia.
    Smith FB; Bradbury AW; Fowkes FG
    Cochrane Database Syst Rev; 2000; (2):CD002070. PubMed ID: 10796677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.
    Williams AJ; Osman J; Skinner C
    Thorax; 1982 Aug; 37(8):617-9. PubMed ID: 7179191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
    Grossmann W; Standl A; May U
    Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
    [No Abstract]   [Full Text] [Related]  

  • 59. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
    Brodie NH
    Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.